Dudediligence.

Bio-Rad Laboratories, Inc

BIO-BNYSE · Laboratory Analytical Instruments
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,046,298

5 notices · 3,487 sh

Oct 2025 to Oct 2026

Reported ·

$349,883

2 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 2 reported sales carry the 10b5-1 box.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-05-28: Alles Institute for Medical Research Corp, Form 1442026-05-11: EVA ENGELHARDT, Form 1442025-12-02: MICHAEL W CROWLEY, Form 1442025-11-18: Alles Institute for Medical Research Corp, Form 1442025-11-06: JAMES BARRY, Form 1442025-11-06: BARRY JAMES, sold2026-05-11: ENGELHARDT EVA ANETTE, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-05-28Alles Institute for Medical Research Corp, Director, 10% Stockholder$219,296
700 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-11EVA ENGELHARDT, EVP, President, CDG$135,597
550 shno plan date144 ↗
Form 4, 2026-05-13: sold 550 at $246.54 Form 4 ↗
2025-12-02MICHAEL W CROWLEY, EVP, GBL Commercial Operations$247,979
776 shno plan dateno Form 4 on file144 ↗
2025-11-18Alles Institute for Medical Research Corp, Director, 10% Stockholder$228,793
760 shno plan dateno Form 4 on file144 ↗
2025-11-06JAMES BARRY, EVP, President, LSG$214,633
701 shno plan date144 ↗
Form 4, 2025-11-10: sold 700 at $306.18The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.104 to $306.230, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc.... Form 4 ↗